BACKGROUND: Advanced glycation end products (AGEs) have been implicated in the pathogenesis of diabetes, heart disease, and kidney failure and may potentially affect skeletal muscle. Whether AGEs are associated with poor muscle strength is unknown. METHODS: Serum carboxymethyl-lysine (CML), a dominant AGE, circulating soluble form of receptor for advanced glycation end products (sRAGE), and endogenous secretory receptor for advanced glycation end product (esRAGE) and grip strength were measured in 559 moderately to severely disabled women, age 65 and older, in the Women's Health and Aging Study I in Baltimore, Md. RESULTS: Mean (standard deviation) grip strength among women in the highest quartile of serum CML compared with women in the lower three quartiles was 18.6 and 20.0 kg, respectively (p = .002), adjusting for age, race, body mass index, cognitive dysfunction, depression, and diabetes. Serum sRAGE and esRAGE were not significantly associated with grip strength. CONCLUSIONS: Women with high serum AGEs have greater muscle weakness. Further studies are needed to determine whether AGEs, a potentially modifiable risk factor, are associated with physical performance and disability in older adults.
BACKGROUND: Advanced glycation end products (AGEs) have been implicated in the pathogenesis of diabetes, heart disease, and kidney failure and may potentially affect skeletal muscle. Whether AGEs are associated with poor muscle strength is unknown. METHODS: Serum carboxymethyl-lysine (CML), a dominant AGE, circulating soluble form of receptor for advanced glycation end products (sRAGE), and endogenous secretory receptor for advanced glycation end product (esRAGE) and grip strength were measured in 559 moderately to severely disabled women, age 65 and older, in the Women's Health and Aging Study I in Baltimore, Md. RESULTS: Mean (standard deviation) grip strength among women in the highest quartile of serum CML compared with women in the lower three quartiles was 18.6 and 20.0 kg, respectively (p = .002), adjusting for age, race, body mass index, cognitive dysfunction, depression, and diabetes. Serum sRAGE and esRAGE were not significantly associated with grip strength. CONCLUSIONS:Women with high serum AGEs have greater muscle weakness. Further studies are needed to determine whether AGEs, a potentially modifiable risk factor, are associated with physical performance and disability in older adults.
Authors: T Rantanen; T Harris; S G Leveille; M Visser; D Foley; K Masaki; J M Guralnik Journal: J Gerontol A Biol Sci Med Sci Date: 2000-03 Impact factor: 6.053
Authors: Marjolein Visser; Stephen B Kritchevsky; Bret H Goodpaster; Anne B Newman; Michael Nevitt; Elizabeth Stamm; Tamara B Harris Journal: J Am Geriatr Soc Date: 2002-05 Impact factor: 5.562
Authors: Taina Rantanen; Stefano Volpato; Luigi Ferrucci; Eino Heikkinen; Linda P Fried; Jack M Guralnik Journal: J Am Geriatr Soc Date: 2003-05 Impact factor: 5.562
Authors: Richard D Semba; Stefania Bandinelli; Kai Sun; Jack M Guralnik; Luigi Ferrucci Journal: Eur J Appl Physiol Date: 2009-09-16 Impact factor: 3.078
Authors: Laís de Faria Fonseca; Anna Beatriz Araújo; Kélcia Rosana da Silva Quadros; Cinthia Esbrile Moraes Carbonara; Sérgio San Juan Dertkigil; Andrei Carvalho Sposito; Rodrigo Bueno de Oliveira Journal: J Bras Nefrol Date: 2021 Apr-Jun
Authors: Matteo Cesari; Roger A Fielding; Marco Pahor; Bret Goodpaster; Marc Hellerstein; Gabor A van Kan; Stefan D Anker; Seward Rutkove; J Willem Vrijbloed; Maria Isaac; Yves Rolland; Christine M'rini; Mylène Aubertin-Leheudre; Jesse M Cedarbaum; Mauro Zamboni; Cornell C Sieber; Didier Laurent; William J Evans; Ronenn Roubenoff; John E Morley; Bruno Vellas Journal: J Cachexia Sarcopenia Muscle Date: 2012-08-03 Impact factor: 12.910